Aortic balloon dilatation for congenital aortic stenosis: report of 90 cases (1986-98).
OBJECTIVE
To review 12 years of experience of balloon aortic valvoplasty in childhood.


METHODS
Early and mid-term clinical and instrumental evaluation of 104 consecutive balloon aortic valvoplasties performed from 1986 to 1998.


METHODS
A tertiary referral centre for congenital heart disease.


METHODS
90 patients with congenital aortic stenosis: 20 neonates (group 1), 16 infants (group 2), and 54 children (group 3).


METHODS
Balloon aortic valvotomy.


METHODS
Doppler and peak to peak aortic gradient before and after valvoplasty, degree of aortic regurgitation before and after valvoplasty, early and late mortality, need for repeat intervention or surgery.


RESULTS
Balloon aortic valvoplasty produced a gradient reduction of > 50% in 59 patients, 12 having a residual peak to peak gradient of > 50 mm Hg. Early mortality included three procedure related and six procedure unrelated deaths. There were no intraprocedural deaths. Grade III aortic regurgitation occurred in 20 patients. Five non-lethal complications occurred. At a mean follow up of 5.1 (group 1), 5.7 (group 2), and 7.6 years (group 3), survival was 75%, 88%, and 96%, respectively. Redilatation was performed in three patients in group 1, one in group 2, and 10 in group 3. Surgery was necessary for six in group 1, one in group 2, and eight in group 3. Freedom from events at last follow up was 50%, 75%, and 64%, respectively. There was a residual maximum Doppler gradient of < 30 mm Hg in 22 patients and > 60 mm Hg in 23; 50 patients have mild to moderate aortic regurgitation.


CONCLUSIONS
Balloon aortic valvoplasty is effective and repeatable and offers good palliation for congenital aortic stenosis in childhood.
Borghi
A
A
Department of Cardiology, Ospedali Riuniti, via Mazzini 12, Bergamo, Italy.
Agnoletti
G
G
Valsecchi
O
O
Carminati
M
M
D000293:Adolescent; D001024:Aortic Valve Stenosis / Q000151:congenital / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D002404:Catheterization / Q000379:methods* / Q000401:mortality; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D016019:Survival Analysis; D016896:Treatment Outcome